Anika Therapeutics Current Cash

Anika Therapeutics (ANIK) currently reports a current cash of $45M as of September 2026. That compares with $58M in the prior-year period — down 22.5% year over year. Use the charts on this page to explore Anika Therapeutics's current cash history and peer comparisons.

Anika Therapeutics's current cash decreased from $58M to $45M — a 22.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anika Therapeutics reported $45M in current cash as of September 2026. That compares with $58M in the prior-year period — down 22.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anika Therapeutics, and consider following ANIK for alerts when major investors trade the stock.

Anika Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANIK with unrelated industries.